Joe Dupere is the founder of Ixaka. Ixaka has raised $54M in total funding. Based in London, United Kingdom.
Joe Dupere is the CEO of Ixaka Ltd., a London-based cell and gene therapy company. Ixaka, formerly Rexgenero Ltd., develops cell-based therapeutic solutions for various conditions. The company raised £40 million in an early-stage financing round in January 2021 and had previously secured approximately $14.2 million in a Series A round in 2016. Ixaka aims to advance its recently acquired synthetic gene delivery platform into clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library